Chromogranin A: Is it a useful marker of neuroendocrine tumors?

Journal of Clinical Oncology

Volumn 25, Issue 15, 2007, Pages 1967-1973

  Campana, Davide ^a   Nori, Francesca ^a   Piscitelli, Lidya ^a   Morselli Labate, Antonio Maria ^a   Pezzilli, Raffaele ^a   Corinaldesi, Roberto ^a   Tomassetti, Paola ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; SOMATOSTATIN DERIVATIVE; TUMOR MARKER; CHGA PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CANCER LOCALIZATION; CANCER STAGING; CELL HYPERPLASIA; CHRONIC DISEASE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ENDOCRINE TUMOR; ENDOSCOPY; ENTEROCHROMAFFIN LIKE CELL; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ZOLLINGER ELLISON SYNDROME; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHROMOGRANIN A; DIAGNOSIS, DIFFERENTIAL; ENTEROCHROMAFFIN-LIKE CELLS; FEMALE; GASTRITIS, ATROPHIC; HUMANS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; ZOLLINGER-ELLISON SYNDROME;

EID: 34249941287     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.10.1535     Document Type: Article

References (26)

1. Deftos LJ: Chromogranin A: Its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocr Rev 12:181-187, 1991
2. O'Connor DT, Deftos LJ: Secretion of chromogranin A by peptide-producing endocrine neoplasms. N Engl J Med 314:1145-1151, 1986
3. Eriksson B, Oberg K: Peptide hormones as tumor markers in neuroendocrine gastrointestinal tumors. Acta Oncol 30:477-483, 1991
4. Schurmann G, Raeth U, Wiedenmann B, et al: Serum chromogranin A in the diagnosis and follow-up of neuroendocrine tumors of the gastroenteropancreatic tract. World J Surg 16:697-701, 1992
5. Syversen U, Mignon M, Bonfils S, et al: Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients. Acta Oncol 32:161-165, 1993
6. Nobels FR, Kwekkeboom DJ, Coopmans W, et al: Chromogranin A as serum marker for neuroendocrine neoplasia: Comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. J Clin Endocrinol Metab 82:2622-2628, 1997
7. Tomassetti P, Migliori M, Simoni P, et al: Diagnostic value of plasma chromogranin A in neuroendocrine tumours. Eur J Gastroenterol Hepatol 13:55-58, 2001
8. Stridsberg M, Oberg K, Li Q, et al: Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. J Endocrinol 144:49-59, 1995
9. Guignat L, Bidart JM, Nocera M, et al: Chromogranin A and the alpha-subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma. Br J Cancer 84:808-812, 2001
10. Oberg K, Janson ET, Eriksson B: Tumour markers in neuroendocrine tumours. Ital J Gastroenterol Hepatol 31:S160-S162, 1999 (suppl 2)
11. Borch K, Stridsberg M, Burman P, et al: Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis. Scand J Gastroenterol 32:198-202, 1997
12. Peracchi M, Gebbia C, Basilisco G, et al: Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids. Eur J Endocrinol 152:443-448, 2005
13. Peracchi M, Conte D, Gebbia C, et al: Plasma chromogranin A in patients with sporadic gastroentero-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1. Eur J Endocrinol 148:39-43, 2003
14. Bashir S, Gibril F, Ojeaburu JV, et al: Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas. Aliment Pharmacol Ther 16:1367-1382, 2002
15. Abou-Saif A, Gibril F, Ojeaburu JV, et al: Prospective study of the ability of serial measurements of serum chromogranin A and gastrin to detect changes in tumor burden in patients with gastrinomas. Cancer 98:249-261, 2003
16. Nehar D, Lombard-Bohas C, Olivieri S, et al: Interest of chromogranin A for diagnosis and follow-up of endocrine tumours. Clin Endocrinol 60:644-652, 2004
17. Stridsberg M, Eriksson B, Oberg K, et al: A comparison between three commercial kits for chromogranin A measurements. J Endocrinol 177:337-341, 2003
18. Panzuto F, Severi C, Cannizzaro R, et al: Utility of combined use of plasma levels of chromogranin A and pancreatic polypeptide in the diagnosis of gastrointestinal and pancreatic endocrine tumors. J Endocrinol Invest 27:6-11, 2004
19. Ferrari L, Seregni E, Lucignani E, et al: Accuracy and clinical correlates of two different methods for chromogranin A assay in neuroendocrine tumors. Int J Biol Markers 19:295-304, 2004
20. Tomassetti P, Campana D, Piscitelli L, et al: Endocrine pancreatic tumors: Factors correlated with survival. Ann Oncol 16:1806-1810, 2005
21. Tomassetti P, Campana D, Piscitelli L, et al: Endocrine tumors of the ileum: Factors correlated with survival. Neuroendocrinology 83:380-386, 2006
22. Seregni E, Ferrari L, Bajetta E, et al: Clinical significance of blood chromogranin A measurement in neuroendocrine tumours. Ann Oncol 12:S69-S72, 2001 (suppl 2)
23. Kleveland O, Syversen U, Slordahl K, et al: Hypergastrinemia as a cause of chromogranin a increase in blood in patients suspected to have neuroendocrine tumor. Digestion 64:71-74, 2001
24. Moattari AR, Deftos LJ, Vinik AI: Effects of sandostatin on plasma chromogranin-A levels in neuroendocrine tumors. J Clin Endocrinol Metab 69:902-905, 1989
25. Giusti M, Sidoti M, Augeri C, et al: Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man. Eur J Endocrinol 150:299-303, 2004
26. Leon A, Torta M, Dittadi R, et al: Comparison between two methods in the determination of circulating chromogranin A in neuroendocrine tumors (NETs): Results of a prospective multicenter observational study. Int J Biol Markers 20:156-168, 2005